Based on the Assura Plc stock forecast from 0 analysts, the average analyst target price for Assura Plc is not available over the next 12 months. Assura Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Assura Plc is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Assura Plc’s stock price was USD 0.64. Assura Plc’s stock price has changed by +0.00% over the past week, +4.95% over the past month and +21.37% over the last year.
No recent analyst target price found for Assura Plc
No recent average analyst rating found for Assura Plc
Company Overview Assura Plc
Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders. At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Read Less
Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a con...Read More
Frequently Asked Questions About Assura Plc (ARSSF) Stock
Stock Target Advisor's fundamental analysis for Assura Plc's stock is Slightly Bullish .
ARSSF stock's dividend yield is 7.37%.
Our analysis grades ARSSF stock's dividend yield at B-. This means that ARSSF stock's dividend yield is above 80% of the stocks in the REIT - Healthcare Facilities sector in the OTC exchange.
Based on this ARSSF may be a good dividend stock for its sector.
Unfortunately we do not have enough data on ARSSF's stock to indicate what its average analyst target is.
ARSSF stock's Price/Earning ratio is 20.20.
Our analysis grades ARSSF stock's Price / Earning ratio at A+. This means that ARSSF stock's Price/Earning ratio is above 0% of the stocks in the REIT - Healthcare Facilities sector in the OTC exchange.
Based on this ARSSF may be undervalued for its sector.
The last closing price of ARSSF's stock was USD 0.64.
The most recent market capitalization for ARSSF is USD 2.15B.
Unfortunately we do not have enough analyst data on ARSSF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Assura Plc's stock.
As per our most recent records Assura Plc has 84 Employees.
Assura Plc's registered address is 3 Barrington Road, Altrincham, United Kingdom, WA14 1GY.
You can get more information about it from Assura Plc's website at https://www.assuraplc.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Assura Plc (ARSSF) Stock
Stock Target Advisor's fundamental analysis for Assura Plc's stock is Slightly Bullish .
ARSSF stock's dividend yield is 7.37%.
Our analysis grades ARSSF stock's dividend yield at B-. This means that ARSSF stock's dividend yield is above 80% of the stocks in the REIT - Healthcare Facilities sector in the OTC exchange.
Based on this ARSSF may be a good dividend stock for its sector.
Unfortunately we do not have enough data on ARSSF's stock to indicate what its average analyst target is.
ARSSF stock's Price/Earning ratio is 20.20.
Our analysis grades ARSSF stock's Price / Earning ratio at A+. This means that ARSSF stock's Price/Earning ratio is above 0% of the stocks in the REIT - Healthcare Facilities sector in the OTC exchange.
Based on this ARSSF may be undervalued for its sector.
The last closing price of ARSSF's stock was USD 0.64.
The most recent market capitalization for ARSSF is USD 2.15B.
Unfortunately we do not have enough analyst data on ARSSF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Assura Plc's stock.
As per our most recent records Assura Plc has 84 Employees.
Assura Plc's registered address is 3 Barrington Road, Altrincham, United Kingdom, WA14 1GY.
You can get more information about it from Assura Plc's website at https://www.assuraplc.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARSSF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
